Pfizer withdraws sickle cell disease treatment on risk of complication, death
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
Pfizer Recalls All of Its Sickle Cell Disease Treatment Over Safety Concerns
Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of safety concerns. Pfizer ( PFE) ...
Pfizer's Oxbryta exit may hasten trials of rival experimental sickle cell drugs, analysts say
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
Deaths lead Pfizer to pull sickle cell drug at center of $5 billion Bay Area buyout
Pfizer had big hopes for a sickle-cell disease drug, as did those suffering from the disease. Things didn't turn out as ...
Medpage Today on MSN1d
Sickle Cell Disease Drug Pulled From Global Markets
Pfizer is pulling its sickle cell disease (SCD) treatment voxelotor (Oxbryta) from global markets after data review showed an ...
Pfizer’s Strategy Looks Shakier After Sickle-Cell Disappointment
The company said it was withdrawing Oxbryta, a daily pill for patients with the disease, a serious, lifelong condition.
‘You Can’t Really Prepare A Person Until They’re In It’: What It’s Like Dating With Sickle Cell Disease
A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...
EU watchdog puts sickle cell disease drug on ice
The EU's drug watchdog Thursday called for the suspension of approval for Pfizer's medicine to treat sickle cell disease, ...
New legislation could 'revolutionize' access to sickle cell disease treatment
On Friday, Sept. 27, lawmakers reintroduced the Sickle Cell Disease Treatment Centers Act. If passed, this bicameral bill ...
Q&A: Shedding light on a neglected form of sickle cell disease
Sickle cell disease (SCD) is a group of painful and life-threatening genetic disorders that affect hemoglobin, the major ...
STAT13h
Sickle cell community scrambles to find safe plan after a drug is pulled from the market
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left scrambling to figure out what to do.
Revolutionary sickle cell treatment providing hope and equity in action
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard for addressing health inequities.